110 ALLEN ROAD, BASKING RIDGE, NJ
Waiver to Agreement and Plan of Merger
Ex-99.1
Lisata Therapeutics Enters Agreement for Acquisition by Kuva Labs
Other Events
Enters Into Term Sheet to be Acquired by Kuva Labs for $4.00 Per Share in an All-Cash Tender Offer
Investor Presentation
Material Contracts
FY 2025
Q3
Q2
Q1
FY 2024
Schedule 14D-9C Solicitation/Recommendation Statement Communication
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload